[1]
|
中华医学会糖尿病学分会. 中国糖尿病防治指南(2024版) [J]. 中华糖尿病杂志, 2025, 17(1): 16-139.
|
[2]
|
Battelino, T., Danne, T., Bergenstal, R.M., et al. (2019) Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations from the International Consensus on Time in Range. Diabetes Care, 42, 1593-1603.
|
[3]
|
Beck, R.W., Connor, C.G., Mullen, D.M., Wesley, D.M. and Bergenstal, R.M. (2017) The Fallacy of Average: How Using Hba1c Alone to Assess Glycemic Control Can Be Misleading. Diabetes Care, 40, 994-999. https://doi.org/10.2337/dc17-0636
|
[4]
|
Rodbard, D. (2017) Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes. Diabetes Technology & Therapeutics, 19, S-25-S-37. https://doi.org/10.1089/dia.2017.0035
|
[5]
|
Bellido, V., Pinés-Corrales, P.J., Villar-Taibo, R. and Ampudia-Blasco, F.J. (2021) Time-in-Range for Monitoring Glucose Control: Is It Time for a Change? Diabetes Research and Clinical Practice, 177, Article ID: 108917. https://doi.org/10.1016/j.diabres.2021.108917
|
[6]
|
Battelino, T., Alexander, C.M., Amiel, S.A., et al. (2023) Continuous Glucose Monitoring and Metrics for Clinical Trials: An International Consensus Statement. The Lancet Diabetes & Endocrinology, 11, 42-57.
|
[7]
|
Hu, Q., Zhang, X., Peng, H., Guan, J., Huang, Z., Jiang, B., et al. (2024) A New Modulator of Neuroinflammation in Diabetic Retinopathy: USP25. Inflammation, 47, 1520-1535. https://doi.org/10.1007/s10753-024-01991-x
|
[8]
|
Beck, R.W., Bergenstal, R.M., Riddlesworth, T.D., Kollman, C., Li, Z., Brown, A.S., et al. (2018) Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials. Diabetes Care, 42, 400-405. https://doi.org/10.2337/dc18-1444
|
[9]
|
王亚昕, 陆静毅, 戴冬君, 等. 2型糖尿病患者葡萄糖在目标范围内时间与视网膜病变相关性的队列研究[J]. 中华糖尿病杂志, 2021, 13(11): 1061-1067.
|
[10]
|
Lu, J., Ma, X., Zhou, J., Zhang, L., Mo, Y., Ying, L., et al. (2018) Association of Time in Range, as Assessed by Continuous Glucose Monitoring, with Diabetic Retinopathy in Type 2 Diabetes. Diabetes Care, 41, 2370-2376. https://doi.org/10.2337/dc18-1131
|
[11]
|
舒涛, 郭正, 王飞, 等. 葡萄糖在目标范围内时间与糖尿病肾脏疾病的相关性研究[J]. 中国全科医学, 2023, 26(15): 1873-1879.
|
[12]
|
王淑倩, 胡秀娟, 印小蓉, 等. 葡萄糖目标范围内时间、葡萄糖管理指标与2型糖尿病肾病风险的相关性[J]. 安徽医科大学学报, 2023, 58(10): 1782-1786.
|
[13]
|
张薇, 钱露, 贺菲菲. 葡萄糖在目标范围内时间与2型糖尿病患者尿白蛋白水平的相关性[J]. 临床医学研究与实践, 2022, 7(13): 4-6.
|
[14]
|
孙增新, 吕鑫, 孔璐璐, 等. 连续血糖监测评估的目标范围内时间与糖尿病肾病的相关性研究[J]. 临床肾脏病杂志, 2022, 22(8): 659-665.
|
[15]
|
Yoo, J.H., Choi, M.S., Ahn, J., Park, S.W., Kim, Y., Hur, K.Y., et al. (2020) Association between Continuous Glucose Monitoring-Derived Time in Range, Other Core Metrics, and Albuminuria in Type 2 Diabetes. Diabetes Technology & Therapeutics, 22, 768-776. https://doi.org/10.1089/dia.2019.0499
|
[16]
|
Jin, X., Yang, X., Xu, Y., Liang, J., Liu, C., Guo, Q., et al. (2023) Differential Correlation between Time in Range and eGFR or Albuminuria in Type 2 Diabetes. Diabetology & Metabolic Syndrome, 15, Article No. 92. https://doi.org/10.1186/s13098-023-01071-4
|
[17]
|
Zhang, Q., Xiao, S., Zou, F., Jiao, X. and Shen, Y. (2025) Continuous Glucose Monitoring-Derived Time in Range and CV Are Associated with Elevated Risk of Adverse Kidney Outcomes for Patients with Type 2 Diabetes. Diabetes & Metabolism, 51, Article ID: 101616. https://doi.org/10.1016/j.diabet.2025.101616
|
[18]
|
Wang, D., Liu, K., Zhang, Y., Yang, J., Heng, H., Deng, X. and Yuan, H. (2021) Association of Time in Range with the Severity of Coronary Artery Disease in Type 2 Diabetic Patients. Chinese Journal of Endocrinology and Metabolism, 973-978.
|
[19]
|
Lu, J., Ma, X., Shen, Y., Wu, Q., Wang, R., Zhang, L., et al. (2020) Time in Range Is Associated with Carotid Intima-Media Thickness in Type 2 Diabetes. Diabetes Technology & Therapeutics, 22, 72-78. https://doi.org/10.1089/dia.2019.0251
|
[20]
|
Lu, J., Wang, C., Shen, Y., Chen, L., Zhang, L., Cai, J., et al. (2020) Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients with Type 2 Diabetes: A Prospective Cohort Study. Diabetes Care, 44, 549-555. https://doi.org/10.2337/dc20-1862
|
[21]
|
Lanspa, M.J., Krinsley, J.S., Hersh, A.M., Wilson, E.L., Holmen, J.R., Orme, J.F., et al. (2019) Percentage of Time in Range 70 to 139 mg/dl Is Associated with Reduced Mortality among Critically Ill Patients Receiving IV Insulin Infusion. Chest, 156, 878-886. https://doi.org/10.1016/j.chest.2019.05.016
|
[22]
|
Guo, J., Wang, J., Zhao, Z. and Yu, L. (2021) Association between Glycemic Control Assessed by Continuous Glucose Monitoring and Stroke in Patients with Atrial Fibrillation and Diabetes Mellitus. Annals of Palliative Medicine, 10, 9157-9164. https://doi.org/10.21037/apm-21-2198
|
[23]
|
Wang, M., et al. (2022) Correlation of Glycemic Variability and Time in Range with Early Neurological Deterioration in Patients with Acute Ischemic Stroke and Diabetes. Chinese General Practice, 25, 1418-1423.
|
[24]
|
Mayeda, L., Katz, R., Ahmad, I., Bansal, N., Batacchi, Z., Hirsch, I.B., et al. (2020) Glucose Time in Range and Peripheral Neuropathy in Type 2 Diabetes Mellitus and Chronic Kidney Disease. BMJ Open Diabetes Research & Care, 8, e000991. https://doi.org/10.1136/bmjdrc-2019-000991
|
[25]
|
Li, F., Zhang, Y., Li, H., Lu, J., Jiang, L., Vigersky, R.A., et al. (2020) TIR Generated by Continuous Glucose Monitoring Is Associated with Peripheral Nerve Function in Type 2 Diabetes. Diabetes Research and Clinical Practice, 166, Article ID: 108289. https://doi.org/10.1016/j.diabres.2020.108289
|
[26]
|
Yang, J., Yang, X., Zhao, D., Wang, X., Wei, W. and Yuan, H. (2020) Association of Time in Range, as Assessed by Continuous Glucose Monitoring, with Painful Diabetic Polyneuropathy. Journal of Diabetes Investigation, 12, 828-836. https://doi.org/10.1111/jdi.13394
|
[27]
|
Guo, Q., Zang, P., Xu, S., Song, W., Zhang, Z., Liu, C., et al. (2020) Time in Range, as a Novel Metric of Glycemic Control, Is Reversely Associated with Presence of Diabetic Cardiovascular Autonomic Neuropathy Independent of Hba1c in Chinese Type 2 Diabetes. Journal of Diabetes Research, 2020, Article ID: 5817074. https://doi.org/10.1155/2020/5817074
|
[28]
|
Li, S., Huang, Z., Lou, D., Jiang, Y. and Zhao, S. (2022) Impact of Time in Range during Hospitalization on Clinical Outcomes in Diabetic Patients with Toe Amputation: A Propensity Score Matching Analysis. BMC Surgery, 22, Article No. 314. https://doi.org/10.1186/s12893-022-01762-1
|
[29]
|
Xie, P., Deng, B., Zhang, X., Li, Y., Du, C., Rui, S., et al. (2021) Time in Range in Relation to Amputation and All‐cause Mortality in Hospitalised Patients with Diabetic Foot Ulcers. Diabetes/Metabolism Research and Reviews, 38, e3498. https://doi.org/10.1002/dmrr.3498
|
[30]
|
Huang, Z., Zhang, H., Huang, Y., Ye, S., Ma, Y., Xin, Y., et al. (2021) Association of Time in Range with Postoperative Wound Healing in Patients with Diabetic Foot Ulcers. International Wound Journal, 19, 1309-1318. https://doi.org/10.1111/iwj.13725
|
[31]
|
Yin, X., Zhu, W., Liu, C., Yao, H., You, J., Chen, Y., et al. (2022) Association of Continuous Glucose Monitoring-Derived Time in Range with Major Amputation Risk in Diabetic Foot Osteomyelitis Patients Undergoing Amputation. Therapeutic Advances in Endocrinology and Metabolism, 13. https://doi.org/10.1177/20420188221099337
|
[32]
|
吴道爱, 金国玺, 时照明, 等. 葡萄糖在目标范围内时间和糖尿病足的相关性研究[J]. 中华全科医学, 2024, 22(3): 414-417.
|
[33]
|
胡炎森, 郭超, 汪茂玉, 等. 葡萄糖目标范围内时间与2型糖尿病创面愈合的相关性研究[J]. 临床内科杂志, 2023, 40(7): 466-470.
|